RKL Wealth Management LLC Reduces Position in Thermo Fisher Scientific Inc (TMO)

RKL Wealth Management LLC lowered its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 11.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,443 shares of the medical research company’s stock after selling 4,342 shares during the quarter. Thermo Fisher Scientific accounts for 1.8% of RKL Wealth Management LLC’s portfolio, making the stock its 14th largest position. RKL Wealth Management LLC’s holdings in Thermo Fisher Scientific were worth $6,522,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. British Airways Pensions Investment Management Ltd boosted its stake in shares of Thermo Fisher Scientific by 17.6% during the 3rd quarter. British Airways Pensions Investment Management Ltd now owns 234,057 shares of the medical research company’s stock worth $44,272,000 after acquiring an additional 35,104 shares during the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Thermo Fisher Scientific by 12.0% during the 3rd quarter. Advisors Asset Management Inc. now owns 72,051 shares of the medical research company’s stock worth $13,632,000 after acquiring an additional 7,717 shares during the last quarter. Commerce Bank boosted its stake in shares of Thermo Fisher Scientific by 2.3% during the 3rd quarter. Commerce Bank now owns 224,186 shares of the medical research company’s stock worth $42,416,000 after acquiring an additional 5,107 shares during the last quarter. Putnam FL Investment Management Co. purchased a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth $5,645,000. Finally, Quadrant Capital Management LLC boosted its stake in shares of Thermo Fisher Scientific by 3.3% during the 3rd quarter. Quadrant Capital Management LLC now owns 14,318 shares of the medical research company’s stock worth $2,709,000 after acquiring an additional 455 shares during the last quarter. Institutional investors own 86.16% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up $1.42 during midday trading on Thursday, reaching $183.87. 2,262,900 shares of the company’s stock were exchanged, compared to its average volume of 1,561,349. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. The company has a market cap of $73,161.61, a P/E ratio of 20.05, a P/E/G ratio of 1.67 and a beta of 1.06. Thermo Fisher Scientific Inc has a one year low of $139.88 and a one year high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.03 EPS. equities analysts anticipate that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a $0.15 dividend. The ex-dividend date is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.33%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

Several research analysts have recently weighed in on TMO shares. Leerink Swann lifted their price target on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research note on Monday, October 9th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price target on the stock in a research note on Thursday, September 21st. Cowen reiterated an “outperform” rating and set a $220.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Sunday, September 10th. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, October 26th. Finally, Barclays restated an “overweight” rating and set a $215.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Monday, September 25th. One research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $205.21.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares in the company, valued at approximately $47,582,981.03. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.49% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “RKL Wealth Management LLC Reduces Position in Thermo Fisher Scientific Inc (TMO)” was published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3080249/rkl-wealth-management-llc-reduces-position-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.